Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina.
Heart Rhythm. 2024 Feb;21(2):153-160. doi: 10.1016/j.hrthm.2023.10.021. Epub 2023 Oct 24.
Cardiac pacemaker implantation after orthotopic heart transplantation declined dramatically after development of the bicaval anastomosis technique. However, much less is known about the rate, indications, and predictors of device implantation procedures with the current surgical technique.
The purpose of this study was to evaluate the indications, patient characteristics, incidence, and survival related to cardiac implantable electronic device (CIED) implantation after heart transplantation.
This was a single-center study of 399 consecutive adult recipients of orthotopic heart transplants with bicaval anastomosis from 1991 to 2017. The primary end point was freedom from pacemaker or implantable cardioverter-defibrillator (ICD) implantation, and the secondary end point was all-cause mortality.
At the time of transplantation, the mean age of recipients was 50 ± 12 years and that of donors 31 ± 12 years. CIEDs were implanted in 8% of recipients (n = 31): 11 pacemakers (35%) for sinus node dysfunction, 17 (55%) for high-grade heart block, and 3 ICDs (10%) for the primary prevention of sudden cardiac death. Early CIED implantation (<30 days) was rare and absent for sinus node dysfunction. The risk for CIED implantation increased progressively during follow-up (0-30 years; median 11 years), with low-, moderate-, and high-risk periods between 0 and 10, between 10 and 20, and between 20 and 30 years, respectively. Recipients receiving CIEDs survived longer after transplantation (21 years vs 13 years; P < .01). Recipients receiving pacemakers for heart block were more likely to receive older donor hearts at the time of transplantation.
The risk of pacemaker implantation increases progressively, while ICD implantation is rare. Donor age is the predominant risk factor for subsequent heart block. Early sinus node dysfunction requiring permanent pacing is rare.
在开发双腔吻合技术后,原位心脏移植后心脏起搏器的植入率显著下降。然而,对于目前的手术技术,关于设备植入程序的发生率、适应证和预测因素,人们知之甚少。
本研究旨在评估心脏移植后心脏植入式电子设备(CIED)植入的适应证、患者特征、发生率和与生存率的关系。
这是一项单中心研究,纳入了 1991 年至 2017 年间接受双腔吻合原位心脏移植的 399 例成年受者。主要终点是免于起搏器或植入式心律转复除颤器(ICD)植入,次要终点是全因死亡率。
在移植时,受者的平均年龄为 50±12 岁,供者的平均年龄为 31±12 岁。8%的受者(n=31)植入了 CIED:11 例(35%)用于窦性心动过缓,17 例(55%)用于高度心脏传导阻滞,3 例(10%)用于心脏性猝死的一级预防。早期(<30 天)CIED 植入罕见,且不存在窦性心动过缓。在随访期间(0-30 年;中位时间 11 年),CIED 植入的风险逐渐增加,低危期、中危期和高危期分别为 0-10 年、10-20 年和 20-30 年。接受 CIED 植入的受者移植后生存时间更长(21 年比 13 年;P<.01)。接受心脏传导阻滞起搏器治疗的受者在移植时更有可能接受年龄较大的供体心脏。
起搏器植入的风险逐渐增加,而 ICD 植入罕见。供体年龄是随后发生心脏传导阻滞的主要危险因素。早期需要永久性起搏的窦性心动过缓罕见。